181 related articles for article (PubMed ID: 26518198)
1. Breast cancer recurrence in relation to antidepressant use.
Chubak J; Bowles EJ; Yu O; Buist DS; Fujii M; Boudreau DM
Cancer Causes Control; 2016 Jan; 27(1):125-36. PubMed ID: 26518198
[TBL] [Abstract][Full Text] [Related]
2. Tamoxifen and Antidepressant Drug Interaction in a Cohort of 16,887 Breast Cancer Survivors.
Haque R; Shi J; Schottinger JE; Ahmed SA; Cheetham TC; Chung J; Avila C; Kleinman K; Habel LA; Fletcher SW; Kwan ML
J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26631176
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer recurrence risk in relation to antidepressant use after diagnosis.
Chubak J; Buist DS; Boudreau DM; Rossing MA; Lumley T; Weiss NS
Breast Cancer Res Treat; 2008 Nov; 112(1):123-32. PubMed ID: 18058227
[TBL] [Abstract][Full Text] [Related]
4. Associations between diabetes medication use and risk of second breast cancer events and mortality.
Calip GS; Yu O; Hoskins KF; Boudreau DM
Cancer Causes Control; 2015 Aug; 26(8):1065-77. PubMed ID: 25956271
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer risk in a large cohort of female antidepressant medication users.
Haque R; Enger SM; Chen W; Petitti DB
Cancer Lett; 2005 Apr; 221(1):61-5. PubMed ID: 15797628
[TBL] [Abstract][Full Text] [Related]
6. Use of antidepressants after colon cancer diagnosis and risk of recurrence.
Pocobelli G; Yu O; Ziebell RA; Aiello Bowles EJ; Fujii MM; Sterrett AT; Boggs JM; Chen L; Boudreau DM; Ritzwoller DP; Hubbard RA; Chubak J
Psychooncology; 2019 Apr; 28(4):750-758. PubMed ID: 30703275
[TBL] [Abstract][Full Text] [Related]
7. [Antidepressants consumption in the global population in France].
Olié JP; Elomari F; Spadone C; Lépine JP
Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
[TBL] [Abstract][Full Text] [Related]
8. Risk of Seizures Associated with Antidepressant Use in Patients with Depressive Disorder: Follow-up Study with a Nested Case-Control Analysis Using the Clinical Practice Research Datalink.
Bloechliger M; Ceschi A; Rüegg S; Kupferschmidt H; Kraehenbuehl S; Jick SS; Meier CR; Bodmer M
Drug Saf; 2016 Apr; 39(4):307-21. PubMed ID: 26650063
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of bisphosphonate use and risk of contralateral breast cancer and recurrence in women with early-stage breast cancer treated with tamoxifen.
Kwan ML; Shi JM; Habel LA; Song J; Chung JW; Avila CC; Schottinger JE; Cheetham TC; Fletcher SW; Haque R
Breast Cancer Res Treat; 2016 Apr; 156(2):379-89. PubMed ID: 27002508
[TBL] [Abstract][Full Text] [Related]
10. Risk of cerebrovascular events associated with antidepressant use in patients with depression: a population-based, nested case-control study.
Chen Y; Guo JJ; Li H; Wulsin L; Patel NC
Ann Pharmacother; 2008 Feb; 42(2):177-84. PubMed ID: 18212255
[TBL] [Abstract][Full Text] [Related]
11. Use of antidepressants and NSAIDs in relation to mortality in long-term breast cancer survivors.
Wernli KJ; Hampton JM; Trentham-Dietz A; Newcomb PA
Pharmacoepidemiol Drug Saf; 2011 Feb; 20(2):131-7. PubMed ID: 21254283
[TBL] [Abstract][Full Text] [Related]
12. Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study.
Kelly CM; Juurlink DN; Gomes T; Duong-Hua M; Pritchard KI; Austin PC; Paszat LF
BMJ; 2010 Feb; 340():c693. PubMed ID: 20142325
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant medication use and breast cancer risk.
Cotterchio M; Kreiger N; Darlington G; Steingart A
Am J Epidemiol; 2000 May; 151(10):951-7. PubMed ID: 10853633
[TBL] [Abstract][Full Text] [Related]
14. Use of Antihypertensive Medications and Risk of Adverse Breast Cancer Outcomes in a SEER-Medicare Population.
Chen L; Chubak J; Boudreau DM; Barlow WE; Weiss NS; Li CI
Cancer Epidemiol Biomarkers Prev; 2017 Nov; 26(11):1603-1610. PubMed ID: 28807926
[No Abstract] [Full Text] [Related]
15. Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer.
Boudreau DM; Yu O; Chubak J; Wirtz HS; Bowles EJ; Fujii M; Buist DS
Breast Cancer Res Treat; 2014 Apr; 144(2):405-16. PubMed ID: 24557337
[TBL] [Abstract][Full Text] [Related]
16. [Antidepressants and tamoxifen: an unrecognized interaction].
Moulis M; Khouri C; Mallaret M
Therapie; 2014; 69(2):178-9. PubMed ID: 24926638
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant Use and Risk of Colorectal Cancer in the Women's Health Initiative.
Kiridly-Calderbank JF; Sturgeon SR; Kroenke CH; Reeves KW
Cancer Epidemiol Biomarkers Prev; 2018 Aug; 27(8):892-898. PubMed ID: 29789327
[No Abstract] [Full Text] [Related]
18. Antidepressant use and the risk of breast cancer: a non-association.
Wang PS; Walker AM; Tsuang MT; Orav EJ; Levin R; Avorn J
J Clin Epidemiol; 2001 Jul; 54(7):728-34. PubMed ID: 11438414
[TBL] [Abstract][Full Text] [Related]
19. Comparative risk of self-harm hospitalization amongst depressive disorder patients using different antidepressants: a population-based cohort study in Taiwan.
Wu CS; Liao SC; Tsai YT; Chang SS; Tsai HJ
Psychol Med; 2017 Jan; 47(1):81-92. PubMed ID: 27659718
[TBL] [Abstract][Full Text] [Related]
20. Effect of concomitant CYP2D6 inhibitor use and tamoxifen adherence on breast cancer recurrence in early-stage breast cancer.
Dezentjé VO; van Blijderveen NJ; Gelderblom H; Putter H; van Herk-Sukel MP; Casparie MK; Egberts AC; Nortier JW; Guchelaar HJ
J Clin Oncol; 2010 May; 28(14):2423-9. PubMed ID: 20385997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
